Lineage Cell Therapeutics, Inc.
Status: Publicly traded
Direct answer
Lineage Cell Therapeutics, Inc. is publicly traded on AMEX under the ticker LCTX.
Lineage Cell Therapeutics, Inc. (LCTX) operates as a biotechnology firm in the clinical trial phase, dedicated to pioneering innovative cell-based treatments for various degenerative conditions across the United States and globally. The company's pipeline features several key therapeutic candidates: OpRegen, a replacement therapy utilizing retinal pigment epithelium cells, is currently undergoing Phase I/IIa...
Can you invest in Lineage Cell Therapeutics, Inc.?
Yes. Lineage Cell Therapeutics, Inc. trades publicly on AMEX as LCTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lineage Cell Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.